Akèy › Kansè poumon › South Carolina › Charleston
Etid klinik pou Kansè poumon nan Charleston, SC
11 etid pou Kansè poumon ap chèche patisipan nan sit nan ak bò kote Charleston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Ap rekriteFaz 3
- Ralph H Johnson VA Medical Center, Charleston
- Medical University of South Carolina, Charleston
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Ap rekriteFaz 3
- Bon Secours Saint Francis Hospital, Charleston
- Medical University of South Carolina, Charleston
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Ap rekriteFaz 3
- Medical University of South Carolina-Hollings Cancer Center ( Site 0045), Charleston
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Ap rekriteFaz 3
- Medical University of South Carolina, Charleston
Health Education Approach to Lung Screening
Ap rekriteVolontè an sante akeyi
- Medical University of South Carolina, Charleston
Prediction Augmented Screening Initiative
Ap rekrite
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Ralph H Johnson VA Medical Center, Charleston
- Medical University of South Carolina, Charleston
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2/3
- Medical University of South Carolina, Charleston
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Medical University of South Carolina, Charleston
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Ap rekriteEtid obsèvasyon
- Medical University of South Carolina (MUSC), Charleston
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
Ap rekriteEtid obsèvasyon
- Ralph H. Johnson VA Health Care System, Charleston
Etid Kansè poumon nan lòt vil
- Houston, TX78 etid
- Boston, MA62 etid
- New York City, NY60 etid
- Los Angeles, CA45 etid
- Arlington, VA41 etid
- Washington, DC41 etid
- Chicago, IL41 etid
- Nashville, TN40 etid
- Baltimore, MD40 etid
- St. Louis, MO39 etid
- Columbus, OH37 etid
- Philadelphia, PA36 etid
Lòt etid nan Charleston
- Depresyon19 etid
- Akidan serebavaskilè18 etid
- Ensifizyans kadyak18 etid
- Kansè Poumon ki pa ti selil16 etid
- Twoub Estres Post-Traumatik16 etid
- Maladi kadyovaskilè15 etid
- Kansè pwostat15 etid
- Kansè (tout kalite)14 etid
- Karsinòm selil skuamèz tèt ak kou14 etid
- Maladi Parkinson13 etid
- Maladi poumon entèstisyèl13 etid
- Kansè nan tete12 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.